Celldex Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
CLDX on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
53 Frontage Road, Suite 220, Hampton, NJ

Insiders trading volume in the past year

Celldex Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Anthony S. Marucci PRESIDENT & CEO, Director $1.08M +$308K +40% Nov 11, 2024
Samuel Bates Martin Svp And Cfo $996K -$1.8M -64.4% Jun 14, 2024
Richard M. Wright Sr. Vp & Cco $708K -$1.58M -69% Jun 13, 2024
Diane C. Young Svp, Chief Medical Officer $600K -$1.59M -72.6% Jun 13, 2024
Margo Heath-Chiozzi Svp Of Regulatory Affairs $450K -$3.28M -87.9% Jun 13, 2024
Freddy A. Jimenez Svp & General Counsel $368K -$269K -42.2% Jun 13, 2024
Elizabeth Crowley Sr. Vp & Cpdo $316K -$2.87M -90.1% Jun 14, 2024
Sarah Cavanaugh Svp Of Corp Affairs & Admin. $62.7K -$703K -91.8% Jun 13, 2024
James J. Marino Director $59.1K Nov 18, 2024
Harry Penner Jr Director Jun 13, 2024
Ronald Pepin Sr. Vp & Cbo Jun 13, 2024
Karen L. Shoos Director Jun 13, 2024
Cheryl Cohen Director Jun 13, 2024
Rita Jain Director Jun 13, 2024
Tibor Keler Executive Vp & Cso Jun 13, 2024
Keith L. Brownlie Director Jun 13, 2024
Herbert J. Conrad Director Jun 13, 2024
Garry Arthur Neil Director Jun 13, 2024

Recent Insider Transactions by Companies or Individuals for Celldex Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.